Latest Regulatory Compliance News

New Hope Corporation has extended its on-market share buy-back program to March 2027, reinforcing its commitment to capital management and shareholder value enhancement. The continuation remains subject to market conditions and company discretion.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

Identitii Limited’s ID8N securities have been reinstated to trading following the close of its recent rights issue and the resolution of a Takeovers Panel application.

Northern Minerals has withdrawn its Extraordinary General Meeting and obtained a court order to defer its 2025 AGM until June 30, 2026, allowing more time for regulatory review. This move supports progress toward a key investment decision for its Browns Range rare earths project.

Oldfields Holdings Limited remains suspended from ASX trading following its failure to lodge critical half-year financial reports after announcing a capital raising.

ABx Group’s maiden mixed rare earth carbonate from Tasmania’s Deep Leads resource has been confirmed radiologically safe by ANSTO, with a second, higher-grade sample expected soon. The development could open doors to key international customers and reduce regulatory complexities.

The ASX has suspended trading in eight companies for failing to lodge their periodic reports on time, raising fresh questions about compliance and market confidence.

Australian Bond Exchange Holdings has completed a $0.98 million placement and is proposing attaching options to raise additional funds, pending shareholder approval.

The Star Entertainment Group reports a $110 million statutory loss for H1 FY26 as it undertakes major operational restructuring and seeks refinancing amid challenging market conditions.

Jade Gas Holdings has completed its appraisal program for the TTCBM Project in Mongolia, setting the stage for regulatory approvals and commercial development of a major domestic gas resource.

The Star Entertainment Group reported a 10% drop in H1 FY26 revenue, offset by a 71% improvement in EBITDA, while navigating ongoing licence suspensions and a critical refinancing process.

Osteopore Limited reported an 11% increase in revenue to $3.06 million for 2025, alongside a wider net loss of $3.72 million as it invests heavily in product development and regulatory compliance. The company also expanded its footprint with a new Singapore subsidiary.